Condition: Pulmonary Embolism Acute Massive · Sponsor: Supergene, LLC
The aim of FORPE Registry is to study the safety and efficacy of the non-immunogenic staphylokinase in patients with massive pulmonary embolism in routine clinical practice.
This description comes directly from the study's public registry record.
Sergey N. Tereschenko, MD, Prof. · 495-150-44-19 · stereschenko@yandex.ru
Always discuss trial participation with your own doctor first.
| Belgorod Regional Clinical Hospital of St. Joseph | Belgorod, Russia | Recruiting |
| Kuzbass Cardiology center | Kemerovo, Russia | Recruiting |
| Center of Neurology and Cardiology | Kirov, Russia | Recruiting |
| Lipetsk City Hospital No. 4 "Lipetsk-Med" | Lipetsk, Russia | Recruiting |
| E.I. Chazov National Medical Research Center of Cardiology | Moscow, Russia | Recruiting |
| F.I. Inozemtsev City Clinical Hospital | Moscow, Russia | Recruiting |
| Moscow Multidisciplinary Clinical Center "Kommunarka" | Moscow, Russia | Recruiting |
| S.P. Botkin City Clinical Hospital | Moscow, Russia | Recruiting |
| S.S. Yudin City Clinical Hospital | Moscow, Russia | Recruiting |
| N.A. Semashko Nizhny Novgorod Regional Clinical Hospital | Nizhny Novgorod, Russia | Recruiting |
| G.A. Zakharyin Clinical hospital №6 | Penza, Russia | Recruiting |
| V.P. Polyakov Samara Regional Clinical Cardiology Dispensary | Samara, Russia | Recruiting |
+ 2 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07245927